ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001

Women PIs Score Highest In RFA To Encourage Early Breast Cancer Detection

May 1, 1987

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004

Waxman Adds NIH Bypass Budget To Authorization Bill, OKs$1.32 Billion for NCI In FY 1984

April 1, 1983

National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg

June 28, 1974

NAB Approves Subcommittee Recommendations On Organ Site Program – NIH Review, One Headquarters

May 21, 1982